• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

U.S. Botulinum Toxin Emerging Markets

  • ID: 364490
  • February 2003
  • Region: United States
  • Frost & Sullivan

Under-Treated Disease States Create Strong Market Opportunity for Off-Label Use of Botulinum Toxin

The clinically proven efficacy of botulinum toxin in under-treated disease states such as pain management, spasticity, and primary and secondary focal dystonia is expected to significantly increase its off-label use in these categories. Indeed, botulinum toxin has relied on off-label sales to drive revenues for many years.
Since current treatment options are few and have limited efficacy, several pharmaceutical companies are expected to target under-treated disease states, as they offer tremendous revenue potential, scope for market expansion, and high growth.

This Frost & Sullivan research is an in-depth analysis of the emerging markets for botulinum toxin in the United States, divided into the non-surgical cosmetic segment and the therapeutic segment. This report discusses major drivers, restraints and challenges governing the market, competitive structure and competitor strategies, analyzes key candidates in clinical trials, besides providing detailed revenue, price, unit, and demand forecasts.

Botulinum Toxin Drives Demand for Prophylactic, Local, READ MORE >

Note: Product cover images may vary from those shown

1Executive Summary
A.Executive Summary

1Executive Summary

2Total Market


2Report Scope and Segmentation

3Current Approved Indications for Botulinum Toxin
4Clinical Trials Involving Botulinum Toxin(s)


6Existing and Future Market Participants
B.Market Dynamics
1Market Drivers (Cosmetic and Therapeutic Segments)
2Market Restraints (Cosmetic and Therapeutic Segments)
3Challenge 1: Limited Product Differentiation Puts Downward Pressure on Prices
4Challenge 2 : Lax Industry Standards Incite More Stringent Regulatory Process Which Impedes Market Growth
5Challenge 3: Lack of Generic Competition Attracts New Entrants and Threatens Market Profit Potential
6Challenge 4 : U.S. Government Actions against Bioterrorism Threaten to Restrict Product Supply
C.Forecasts and Trends

1Demand Analysis

2Revenue Forecasts

3Market Engineering Analysis

4Market and Technology Trends

5New Technology Developments
D.Competitive Analysis

1Competitive Structure and Competitor Strategies

2Product Analysis

3Market Share Analysis

3Botulinum Toxin Cosmetic Applications


2Non-Surgical Cosmetic Market Analysis
B.Forecasts and Market Trends

1Demand Analysis

2Patient and Procedure Forecasts

3Pricing Analysis and Trends

4Revenue Forecasts

5Market Share Analysis

6Market Engineering Analysis

7Combination Treatment Trends

4Botulinum Toxin Therapeutic Applications


2Botulinum Toxin Dystonia Market

3Botulinum Toxin Spasticity Market

4Botulinum Toxin Pain Management Market
B.Forecasts and Market Trends

1Patient and Procedure Forecasts

2Price Trends and Analysis

3Revenue Forecasts

4Market Share Analysis

5Market Engineering Analysis

6Combination Treatment Trends

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown


Our Clients

Dow Chemical Co Ltd. Huntsman Corporation Evonik Industries AG Cytec Industries Incorporated Invista Akzo Nobel N.V.